These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 16198776

  • 1. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM, Fett DD, Bloomfield HE, Grill JP, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA.
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [Abstract] [Full Text] [Related]

  • 2. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK, Gover MD, Lynde CW.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [Abstract] [Full Text] [Related]

  • 3. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R.
    J Dermatolog Treat; 2006 Nov; 17(1):38-44. PubMed ID: 16467022
    [Abstract] [Full Text] [Related]

  • 4. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK, Konnikov N, Lynde CW.
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [Abstract] [Full Text] [Related]

  • 5. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK, Lynde CW, Konnikov N.
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [Abstract] [Full Text] [Related]

  • 6. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J.
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A, Fellman S, Kianifard F.
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [Abstract] [Full Text] [Related]

  • 8. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD, Medvesovsky E, Shalev R, Biton A, Chetov T, Naimer S, Shai A, Vardy DA.
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [Abstract] [Full Text] [Related]

  • 9. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK, Lynch LE, Kogan N, Cooper EA.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
    Tausch I, Bräutigam M, Weidinger G, Jones TC.
    Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis.
    Pavlotsky F, Armoni G, Shemer A, Trau H.
    J Dermatolog Treat; 2004 Sep; 15(5):315-20. PubMed ID: 15370400
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B.
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S, Nir N, Henri T.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.